BAKER JULIAN
SEC CIK 1087939 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KALA | KALA BIO, Inc. | Former 10% owner | 888.0K | — | $1.06M | 1 | 2025-09-30 | 2025-09-30 |
| VTVT | vTv Therapeutics Inc. | Dir | 12.4K | — | — | 1 | 2025-09-03 | 2025-09-03 |
| KNSA | Kiniksa Pharmaceuticals International, plc | Dir | 2.74M | — | — | 2 | 2024-06-05 | 2025-06-03 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Dir | 1.61M | $19.94M | — | 2 | 2023-11-14 | 2023-11-21 |
| ACAD | ACADIA PHARMACEUTICALS INC | Dir, 10% | 39.33M | — | — | 1 | 2023-06-01 | 2023-06-01 |
| INCY | Incyte | Dir, 10% | 33.44M | $106.95M | — | 2 | 2022-02-10 | 2023-03-13 |
Most active insiders at KALA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | BAKER JULIAN | Former 10% owner | — | $1.06M |
| 2 | Iwicki Mark T | Dir | — | $125.5K |
| 3 | Bazemore Todd | Dir | — | $39.6K |
| 4 | Brazzell Romulus K | SEE REMARKS | — | $38.8K |
| 5 | Reumuth Mary | CFO | — | $27.5K |
| 6 | Kharabi Darius | Chief BUSINESS Off | — | $17.3K |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-10-02 | 2025-09-30+ | KALA | KALA BIO, Inc. | BAKER JULIAN | Former 10% owner | S - Sale | $1.45 | -730.4K | 888.0K | -45% | -$1.06M |
| DMI | 2025-09-05 | 2025-09-03 | VTVT | vTv Therapeutics Inc. | BAKER JULIAN | Dir | A - Grant | — | +51.0K | 12.4K | New | — |
| DMI | 2025-06-05 | 2025-06-03 | KNSA | Kiniksa Pharmaceuticals International, plc | BAKER JULIAN | Dir | A - Grant | $0.00 | +16.8K | 2.74M | +0.6% | $0 |
| DMI | 2024-06-07 | 2024-06-05 | KNSA | Kiniksa Pharmaceuticals International, plc | BAKER JULIAN | Dir | A - Grant | $0.00 | +12.7K | 124.1K | +11% | $0 |
| MI | 2023-11-21 | 2023-11-21 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | BAKER JULIAN | Dir | P - Purchase | $188.47 | +64.3K | 1.61M | +4% | +$12.13M |
| MI | 2023-11-15 | 2023-11-14+ | MDGL | MADRIGAL PHARMACEUTICALS, INC. | BAKER JULIAN | Dir | P - Purchase | $158.13 | +49.4K | 1.55M | +3% | +$7.81M |
| DMI | 2023-06-05 | 2023-06-01 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER JULIAN | Dir, 10% | A - Grant | $0.00 | +26.6K | 39.33M | +0.1% | $0 |
| DMI | 2023-03-15 | 2023-03-13 | INCY | Incyte | BAKER JULIAN | Dir, 10% | M - OptEx | $22.74 | +40.0K | 33.44M | +0.1% | +$909.6K |
| MI | 2022-02-14 | 2022-02-10+ | INCY | Incyte | BAKER JULIAN | Dir, 10% | P - Purchase | $66.91 | +1.60M | 30.98M | +5% | +$106.95M |
Purchase Sale Sale after option exercise All abbreviations